Key risks
- Revenue declined 21.8% from ₹17.24 Cr (Mar 2024) to approximately ₹13 Cr average in recent quarters—verify whether structural customer loss, end-market slowdown, or product cycle effects explain the contraction.
- Operating margins compressed from 36.1% (Mar 2024) to 28–32% (recent quarters)—identify whether cost inflation, product mix shift, or pricing pressure are primary drivers.
- Zero institutional investor participation (FII/DII both 0%) despite dividend yield and positive ROE—suggests either limited market awareness, perceived liquidity constraints, or unidentified business risks.
- Small market capitalisation (₹242 Cr) and narrow trading range indicate limited liquidity, increasing vulnerability to shocks and constraining growth-financing options.
Generated analysis · source review pending